The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis.

[1]  J. Hirsh,et al.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[2]  K. Ghosh,et al.  A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[3]  S. Kahn,et al.  Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. , 2006, The Journal of rheumatology.

[4]  M Greaves,et al.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. , 2006, Health technology assessment.

[5]  M. Shakeri,et al.  COMPARISON OF ANTIPHOSPHOLIPID ANTIBODIES BETWEEN PREECLAMPTSIA AND NORMAL PREGNANT WOMEN , 2006 .

[6]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[7]  P. Langhorne,et al.  Thrombophilia in pregnancy: a systematic review , 2006, British journal of haematology.

[8]  A. Tincani,et al.  Proposals for the measurement of anti‐β2‐glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies , 2004, Journal of thrombosis and haemostasis : JTH.

[9]  K. Ward,et al.  Anticardiolipin and anti-β2-glycoprotein-I antibodies in preeclampsia , 2003 .

[10]  D. Alarcón-Segovia,et al.  Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy. , 2002, Archives of medical research.

[11]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[12]  J. Moodley,et al.  Antibodies to oxidised low-density lipoproteins and cardiolipin in pre-eclampsia and eclampsia , 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[13]  R W Platt,et al.  A new and improved population-based Canadian reference for birth weight for gestational age. , 2001, Pediatrics.

[14]  Z. Alfirevic,et al.  Postnatal Screening for Thrombophilia in Women With Severe Pregnancy Complications , 2001, Obstetrics and gynecology.

[15]  G. Hédelin,et al.  Antiphospholipid Antibodies and Preeclampsia: A Case‐Control Study , 2001, Obstetrics and gynecology.

[16]  M. Petri.  Epidemiology of the antiphospholipid antibody syndrome. , 2000, Journal of autoimmunity.

[17]  R. Strauss.  Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. , 2000, JAMA.

[18]  A. Franx,et al.  High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. , 2000, American journal of obstetrics and gynecology.

[19]  R. Strauss.  Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. , 2000, JAMA.

[20]  A. Fotopoulos,et al.  Anticardiolipin antibodies levels in healthy pregnant and non-pregnant woman , 2000, Archives of Gynecology and Obstetrics.

[21]  A. Gori,et al.  Usefulness of Screening for Congenital or Acquired Hemostatic Abnormalities in Women with Previous Complicated Pregnancies , 1999, Pathophysiology of Haemostasis and Thrombosis.

[22]  M. Reid,et al.  Lupus anticoagulant in Jamaican primiparae and the clinical significance in asymptomatic patients. , 1999, The West Indian medical journal.

[23]  R. Silver,et al.  Anti–β2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome , 1999 .

[24]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[25]  J. Ernerudh,et al.  A prospective study on the occurrence of autoantibodies in low-risk pregnancies. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[26]  W. Dietz,et al.  Growth and development of term children born with low birth weight: effects of genetic and environmental factors. , 1998, The Journal of pediatrics.

[27]  C. Turan,et al.  Antiphospholipid Antibodies in Eclamptic Women , 1998, Gynecologic and Obstetric Investigation.

[28]  R. Tait,et al.  Risk Factors for Pregnancy Associated Venous Thromboembolism , 1997, Thrombosis and Haemostasis.

[29]  Joshua R. Smith,et al.  Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[30]  A. Tincani,et al.  Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[31]  G. Uncu,et al.  Anticardiolipin antibodies in pregnancy induced hypertension. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[32]  J. Allen,et al.  Antiphospholipid Antibodies in Patients With Preeclampsia , 1996, American journal of reproductive immunology.

[33]  Y. Sasamori,et al.  Anti‐Phospholipid Antibodies in Preeclampsia and Their Binding Ability for Placental Villous Lipid Fractions , 1996, The journal of obstetrics and gynaecology research.

[34]  E. Matsuura,et al.  beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. , 1996, Human reproduction.

[35]  K. Takakuwa,et al.  Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy , 1995, Obstetrics and gynecology.

[36]  R. Marlar,et al.  Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: a prospective study , 1995, Lupus.

[37]  V. Bhoola,et al.  The association of antiphospholipid antibodies with severe early-onset pre-eclampsia. , 1995, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[38]  A. Caruso,et al.  Poor pregnancy outcome and anticardiolipin antibodies. , 1994, Fetal diagnosis and therapy.

[39]  F. Parazzini,et al.  Antiphospholipid antibodies and risk of intrauterine late fetal death , 1994, Acta obstetricia et gynecologica Scandinavica.

[40]  R. Marlar,et al.  Antiphospholipid Antibodies in Predicting Adverse Pregnancy Outcome: A Prospective Study , 1994, Annals of Internal Medicine.

[41]  N. Pattison,et al.  Antiphospholipid antibodies in pregnancy: prevalence and clinical associations , 1993, British journal of obstetrics and gynaecology.

[42]  L. Kornman,et al.  A prospective study of pregnancy outcome in women screened at a routine antenatal clinic for anticardiolipin antibodies , 1993, British journal of obstetrics and gynaecology.

[43]  G. Hughes,et al.  Systemic Lupus Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of 1,000 Patients , 1993 .

[44]  M. Dueholm,et al.  Lupus anticoagulant and anticardiolipin antibodies in an obstetric population , 1992, Acta obstetricia et gynecologica Scandinavica.

[45]  B. Paniel,et al.  The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. , 1991, American journal of obstetrics and gynecology.

[46]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.

[47]  J. Sánchez-Guerrero,et al.  Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients , 1989, Medicine.

[48]  J. Hobbins,et al.  The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. , 1989, American journal of obstetrics and gynecology.

[49]  B. Ransil,et al.  Maternal Mortality in Massachusetts—Trends and Prevention , 1987, The New England journal of medicine.

[50]  G. Hughes,et al.  The anticardiolipin syndrome. , 1985, The Journal of rheumatology.

[51]  G. Haugen,et al.  PREECLAMPSIA AND FETAL GROWTH RETARDATION: IS THERE AN ASSOCIATION WITH ANTIPHOSPHOLIPID ANTIBODIES? , 1998 .

[52]  W. Dietz,et al.  Effects of intrauterine growth retardation in premature infants on early childhood growth. , 1997, The Journal of pediatrics.

[53]  R. Strauss,et al.  Effects of the intrauterine environment on childhood growth. , 1997, British medical bulletin.